Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma

Molecular Cancer Research

Volumn 7, Issue 1, 2009, Pages 12-22

  Wang, Xiao Chun ^a   Wu, Yu Peng ^a   Ye, Bo ^b   Lin, De Chen ^a   Feng, Yan Bin ^a   Zhang, Zi Qiang ^c   Xu, Xin ^a   Han, Ya Ling ^a   Cai, Yan ^a   Dong, Jin Tang ^d   Zhan, Qi Min ^a   Wu, Min ^a   Wang, Ming Rong ^a,e  

^a State Key Laboratory of Molecular Oncology   (China)

^b Department of Thoracic Surgery ^*  (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA; SOMATOMEDIN C;

ANOIKIS; ARTICLE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CHROMOSOME 5; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANOIKIS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; DNA PRIMERS; ESOPHAGEAL NEOPLASMS; GENE AMPLIFICATION; HUMANS; LYMPHATIC METASTASIS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLASMIDS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, NEOPLASM; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 58649121716     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0092     Document Type: Article

References (37)

1. Bockmuhl U, Petersen S, Schmidt S, et al. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primaryhead and neck carcinomas. Cancer Res 1997;57:5213-6.
2. Wei F, Ni J, Wu SS, et al. Cytogenetic studies of esophageal squamous cell carcinomas in the northern Chinese population bycomparative genomic hybridization. Cancer Genet Cytogenet 2002;138:38-43.
3. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene 2002;21:6877-83.
4. Bjorkqvist AM, Husgafvel-Pursiainen K, Anttila S, et al. DNA gains in 3q occur frequentlyin squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer 1998;22:79 -82.
5. Zhang H, Kobayashi R, Galaktionov K, Beach D. p19Skp1 and p45Skp2 are essential elements ofthe cyclin A-CDK2 S phase kinase. Cell 1995;82:915-25.
6. Demetrick DJ, Zhang H, Beach DH. Chromosomal mapping of the genes for the human CDK2/cyclin A-associated proteins p19 (SKP1A and SKP1B) and p45 (SKP2). Cytogenet Cell Genet 1996;73:104-7.
7. Nakayama K, Nagahama H, Minamishima YA, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 2000;19:2069-81.
8. Bhattacharya S, Garriga J, Calbo J, Yong T, Haines DS, Grana X. SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 2003;22:2443-51.
9. Tedesco D, Lukas J, Reed SI. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev 2002;16:2946-57.
10. Kamura T, Hara T, Kotoshiba S, et al. Degradation of p57Kip2 mediated bySCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci U S A 2003;100: 10231 -6.
11. Bornstein G, Bloom J, Sitry-Shevah D, Nakayama K, Pagano M, Hershko A. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 2003;278:25752-7.
12. von der Lehr N, Johansson S, Wu S, et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 2003;11:1189-200.
13. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, TanseyWP. Skp2 regulates Myc protein stability and activity. Mol Cell 2003;11:1177-88.
14. Masuda TA, Inoue H, Sonoda H, et al. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 2002;62:3819-25.
15. Yokoi S, Yasui K, Saito-Ohara F, et al. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol 2002;161:207-16.
16. Gstaiger M, Jordan R, Lim M, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A 2001;98:5043 -8.
17. Fukuchi M, Masuda N, Nakajima M, et al. Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in earlyesophageal squamous cell carcinoma. Anticancer Res 2004;24:777 - 83.
18. Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J 2003;22: 2318-23.
19. Shintani S, Li C, Mihara M, Hino S, Nakashiro K, Hamakawa H. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas. Oncology2003;65:355 -62.
20. Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. S-phase kinaseassociated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications. Oncol Rep 2003;10:321 -5.
21. Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 2001;61:7044-7.
22. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619-26.
23. Frisch SM,ScreatonRA. Anoikismechanisms. CurrOpinCellBiol2001;13: 555-62.
24. Hanahan D, Weinberg RA. The hallmarks ofcancer. Cell 2000;100:57-70.
25. Bourguignon LY, Zhu H, Shao L, Chen YW. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem 2001;276:7327 -36.
26. Ramachandra M, Atencio I, Rahman A, et al. Restoration of transforming growth factor signaling byfunctional expression of βsmad4 induces anoikis. Cancer Res 2002;62:6045-51
27. 1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. Mol Cell Biol 2005;25: 5282-91.
28. Kim HR, Lin HM, Biliran H, Raz A. Cell cycle arrest and inhibition of anoikis bygalectin-3 in human breast epithelial cells. Cancer Res 1999;59: 4148 -54.
29. Reginato MJ, Mills KR, Paulus JK, et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 2003;5: 733-40.
30. Reichert M, Saur D, Hamacher R, Schmid RM, Schneider G. Phosphoi-nositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. Cancer Res 2007;67:4149-56.
31. Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006;6:369-81.
32. Andreu EJ, Lledo E, Poch E, et al. BCR-ABL induces the expression ofSkp2 through the PI3K pathwayto promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Cancer Res 2005;65:3264-72.
33. Sen S, Zhou H, Zhang RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 2002;94:1320 -9.
34. Zhu CQ, Blackhall FH, Pintilie M, et al. Skp2 gene copynumber aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker. Clin Cancer Res 2004;10:1984-91.
35. Kudo Y, Takata T, Yasui W, et al. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma. Cancer 1998;83:2447-55.
36. Kudo Y, Kitajima S, Ogawa I, Kitagawa M, Miyauchi M, Takata T. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells byinhibiting p27 degradation. Mol Cancer Ther 2005; 4:471 -6.
37. Han Y, Wei F, Xu X, et al. Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002;19:455-7.